glucose, (beta-d)-isomer has been researched along with Inappropriate ADH Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carney, EF | 1 |
| Christ-Crain, M; Ebrahimi, F; Imber, C; Jeanloz, N; Kutz, A; Potasso, L; Refardt, J; Sailer, CO; Urwyler, SA; Vogt, DR; Widmer, A; Winzeler, B | 1 |
| Christ-Crain, M; Nobbenhuis, R; Refardt, J; Sailer, CO; Vogt, D; Winzeler, B | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis.
Topics: Aged; Benzhydryl Compounds; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Glucosides; Hospitalization; Hospitals, University; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Risk Assessment; Sodium-Glucose Transporter 2 Inhibitors; Switzerland; Treatment Outcome | 2020 |
2 other study(ies) available for glucose, (beta-d)-isomer and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Efficacy of empagliflozin for syndrome of inappropriate antidiuresis.
Topics: Benzhydryl Compounds; Glucosides; Humans; Hyponatremia; Inappropriate ADH Syndrome | 2023 |
Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Topics: Aged; Benzhydryl Compounds; Biomarkers; C-Reactive Protein; Female; Glucosides; Glycopeptides; Humans; Inappropriate ADH Syndrome; Inflammation; Male; Middle Aged; Natriuretic Peptides; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors | 2021 |